Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03884998
Title Copanlisib and Nivolumab in Treating Participants With Richter's Transformation or Transformed Indolent Non-Hodgkin's Lymphoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OHSU Knight Cancer Institute
Indications

lymphoplasmacytic lymphoma

marginal zone B-cell lymphoma

non-Hodgkin lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

Richter's syndrome

Therapies

Copanlisib + Nivolumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.